Abeona Therapeutics Inc (NASDAQ: ABEO) stock closed at $4.71 on 5/15/24 after a major increase of 12.1%. Moreover, above average trading volume at 143% of normal accompanied the advance. The stock has risen 3.3% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ABEO is expected to continue to be Value Creation neutral.
Abeona Therapeutics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Abeona Therapeutics has a very low Appreciation Score of 0 but a good Power Rating of 84, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment